TABLE 2.
Systemic impairment at baseline, in the overall study population and by presence of mild/complex multimorbidity.
| System, n (%) | Overall (N = 390) | No multimorbidity (N = 84) | Mild multimorbidity (N = 106) | Complex multimorbidity (N = 200) |
|---|---|---|---|---|
| Diseases of the cardiocirculatory system | 276 (70.8) | 23 (27.4) | 78 (73.6) | 175 (87.5) |
| Diseases of the endocrine and metabolic system | 270 (69.2) | 32 (38.1) | 71 (67.0) | 167 (83.5) |
| Diseases of the genitourinary system | 116 (29.7) | 2 (2.4) | 9 (8.5) | 105 (52.5) |
| Musculoskeletal conditions | 114 (29.2) | 3 (3.6) | 23 (21.7) | 88 (44.0) |
| Diseases of the digestive system | 54 (13.9) | 2 (2.4) | 5 (4.7) | 47 (23.5) |
| Diseases of the respiratory system | 49 (12.6) | 3 (3.6) | 7 (6.6) | 39 (19.5) |
| Hematological and immunological conditions | 47 (12.1) | 2 (2.4) | 2 (1.9) | 43 (21.5) |
| Diseases of the eye | 37 (9.5) | 1 (1.2) | 4 (3.8) | 32 (16.0) |
| Cancers | 35 (9.0) | 0 (0.0) | 2 (1.9) | 33 (16.5) |
| Diseases of the ear, nose, and throat | 22 (5.6) | 1 (1.2) | 2 (1.9) | 19 (9.5) |
| Infectious diseases | 2 (0.5) | 0 (0.0) | 0 (0.0) | 2 (1.0) |
| Skin conditions | 1 (0.3) | 0 (0.0) | 0 (0.0) | 1 (0.5) |